Esperson Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Desoximetasone

Indications/Uses

Relief inflammatory & pruritic manifestation of corticosteroid responsive dermatoses.

Click to view Esperson detailed prescribing information

Dosage/Direction for Use

Apply sparingly 1-2 times daily to affected area; if required 3 times daily.

Click to view Esperson detailed prescribing information

Contraindications

Hypersensitivity to desoximetasone or other betamethasone-type corticosteroids. Not to be used on the eyes. May cause leaking or breaking of latex condoms. Patients w/ skin reactions resulting from vaccinations, cutaneous manifestations of TB, syphilis, viral infections eg, chickenpox, rosacea & perioral dermatitis. Pregnancy & lactation.

Click to view Esperson detailed prescribing information

Special Precautions

Patients w/ symptoms of visual disturbances eg, blurred vision should be referred to ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases eg, central serous chorioretinopathy. Possibility of adrenal suppression in prolonged use & application to large skin areas. Periodically evaluate for evidence of hypothalamic-pituitary-adrenal axis suppression. Increased IOP can develop if small doses of topical corticosteroids come into repeated contact w/ the conjunctival sac. Discontinue use if irritation develops & if favorable response does not occur promptly. Must only be used for symptomatic therapy of bacterial &/or mycotic skin infections in combination w/ concomitant antibacterial & antimycotic treatment. Infant & childn <6 yr.

Click to view Esperson detailed prescribing information

Use In Pregnancy & Lactation

Click to view Esperson detailed prescribing information

Adverse Reactions

Folliculitis, hypertrichosis, acne, hyper- or hypopigmentation, telangiectasis, striae distensae, skin atrophy & maceration, burning, itching, irritation, dryness, perioral dermatitis, allergic contact dermatitis & secondary infection.

Click to view Esperson detailed prescribing information

Storage

View Esperson storage conditions for details to ensure optimal shelf-life.

Description

View Esperson description for details of the chemical structure and excipients (inactive components).

Action

View Esperson mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Topical Corticosteroids

ATC Classification

D07AC03 - desoximetasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Esperson oint 0.25%

Packing/Price

15 g x 1's (Rp167,801/tube);5 g x 1's (Rp67,811/tube)

Esperson

desoximetasone

Manufacturer:

Kalventis Sinergi Farma